• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Guttae Morphology After Cultured Corneal Endothelial Cell Transplant in Fuchs Endothelial Corneal Dystrophy.Fuchs 内皮角膜营养不良行培养角膜内皮细胞移植术后的角膜后弹力层小滴形态。
JAMA Ophthalmol. 2024 Sep 1;142(9):818-826. doi: 10.1001/jamaophthalmol.2024.2718.
2
Differences in Guttae Ultramorphology in Relation to Visual Function in Fuchs Endothelial Corneal Dystrophy.福克丝内皮细胞营养不良的超微结构胶滴与视觉功能的关系。
Cornea. 2024 Nov 1;43(11):1348-1354. doi: 10.1097/ICO.0000000000003504. Epub 2024 Feb 23.
3
Corneal Guttae After Descemet Membrane Endothelial Keratoplasty.Descemet 膜内皮角膜移植术后角膜后弹力层小泡。
Cornea. 2024 Feb 1;43(2):146-153. doi: 10.1097/ICO.0000000000003287. Epub 2023 Apr 21.
4
Descemet's membrane endothelial keratoplasty (DMEK) versus Descemet's stripping automated endothelial keratoplasty (DSAEK) for corneal endothelial failure.用于角膜内皮功能衰竭的后弹力层内皮角膜移植术(DMEK)与后弹力层剥除自动内皮角膜移植术(DSAEK)的比较
Cochrane Database Syst Rev. 2018 Jun 25;6(6):CD012097. doi: 10.1002/14651858.CD012097.pub2.
5
[Patient- and donor-dependent factors in descemet membrane endothelial keratoplasty and their impact on visual acuity and quality of life].[角膜后弹力层内皮角膜移植术中患者及供体相关因素及其对视力和生活质量的影响]
Ophthalmologie. 2025 May 13. doi: 10.1007/s00347-025-02238-2.
6
Mediators of Visual Acuity in Descemet Membrane Endothelial Keratoplasty and Ultrathin Descemet Stripping Automated Endothelial Keratoplasty.Descemet 膜内皮角膜移植术和超薄 Descemet 撕囊自动化角膜内皮移植术中视力的介质。
Cornea. 2024 Jul 1;43(7):853-859. doi: 10.1097/ICO.0000000000003434. Epub 2023 Nov 21.
7
Three-Dimensional Assessment of Descemet Membrane Reflectivity by Optical Coherence Tomography in Fuchs Endothelial Corneal Dystrophy.光学相干断层扫描对 Fuchs 内皮角膜营养不良中角膜后弹力层反射率的三维评估。
Cornea. 2024 Feb 1;43(2):207-213. doi: 10.1097/ICO.0000000000003356. Epub 2023 Jul 27.
8
Endothelial keratoplasty versus penetrating keratoplasty for Fuchs endothelial dystrophy.内皮角膜移植术与穿透性角膜移植术治疗富克斯内皮营养不良的比较。
Cochrane Database Syst Rev. 2011 Jul 6(7):CD008420. doi: 10.1002/14651858.CD008420.pub2.
9
Comparative Analysis of Corneal Morphological and Optical Parameters in Predicting DSAEK Surgery Outcome.角膜形态学和光学参数对预测深板层角膜内皮移植术手术结果的对比分析
Medicina (Kaunas). 2025 May 31;61(6):1022. doi: 10.3390/medicina61061022.
10
Outcomes of Descemet Stripping Only Without Postoperative Use of Topical Rho-Associated Protein Kinase Inhibitors.仅行后弹力层剥除术且术后未使用局部 Rho 相关蛋白激酶抑制剂的治疗效果。
Cornea. 2024 Dec 1;43(12):1516-1521. doi: 10.1097/ICO.0000000000003619. Epub 2024 Jun 28.

引用本文的文献

1
Regional Variation in Guttae Distribution in Fuchs Endothelial Corneal Dystrophy.富克斯内皮性角膜营养不良中角膜小滴分布的区域差异
Ophthalmol Sci. 2025 May 2;5(5):100817. doi: 10.1016/j.xops.2025.100817. eCollection 2025 Sep-Oct.

本文引用的文献

1
Twelve-year outcome of Rho-associated protein kinase inhibitor eye drop treatment for Fuchs endothelial corneal dystrophy: A case study.Rho相关蛋白激酶抑制剂滴眼液治疗Fuchs内皮角膜营养不良的12年随访结果:一项病例研究
Am J Ophthalmol Case Rep. 2023 Mar 31;30:101839. doi: 10.1016/j.ajoc.2023.101839. eCollection 2023 Jun.
2
Recurrence of Guttae and Endothelial Dysfunction After Successful Descemet Stripping Only in Fuchs Dystrophy.仅在 Fuchs 营养不良中成功进行 Descemet 膜撕除术后出现胶滴和内皮功能障碍的复发。
Cornea. 2023 Aug 1;42(8):1037-1040. doi: 10.1097/ICO.0000000000003221. Epub 2022 Dec 19.
3
Superiority of Mature Differentiated Cultured Human Corneal Endothelial Cell Injection Therapy for Corneal Endothelial Failure.成熟分化的培养人角膜内皮细胞注射疗法治疗角膜内皮功能衰竭的优越性
Am J Ophthalmol. 2022 May;237:267-277. doi: 10.1016/j.ajo.2021.11.012. Epub 2021 Nov 14.
4
A Close Look at the Clinical Efficacy of Rho-Associated Protein Kinase Inhibitor Eye Drops for Fuchs Endothelial Corneal Dystrophy.深入观察 Rho 相关蛋白激酶抑制剂滴眼剂治疗 Fuchs 内皮角膜营养不良的临床疗效。
Cornea. 2021 Oct 1;40(10):1225-1228. doi: 10.1097/ICO.0000000000002642.
5
Randomized, Double-Masked, Pilot Study of Netarsudil 0.02% Ophthalmic Solution for Treatment of Corneal Edema in Fuchs Dystrophy.随机、双盲、奈他舒地尔 0.02%滴眼液治疗 Fuchs 营养不良性角膜水肿的初步研究。
Am J Ophthalmol. 2021 Jul;227:100-105. doi: 10.1016/j.ajo.2021.03.006. Epub 2021 Mar 15.
6
Potential Functional Restoration of Corneal Endothelial Cells in Fuchs Endothelial Corneal Dystrophy by ROCK Inhibitor (Ripasudil).ROCK抑制剂(瑞帕舒迪)对Fuchs内皮角膜营养不良中角膜内皮细胞的潜在功能恢复作用
Am J Ophthalmol. 2021 Apr;224:185-199. doi: 10.1016/j.ajo.2020.12.006. Epub 2020 Dec 11.
7
Mitochondria as a Platform for Dictating the Cell Fate of Cultured Human Corneal Endothelial Cells.线粒体作为决定培养的人眼角膜内皮细胞命运的平台。
Invest Ophthalmol Vis Sci. 2020 Dec 1;61(14):10. doi: 10.1167/iovs.61.14.10.
8
Five-Year Follow-up of First 11 Patients Undergoing Injection of Cultured Corneal Endothelial Cells for Corneal Endothelial Failure.首批11例接受培养角膜内皮细胞注射治疗角膜内皮失代偿患者的五年随访
Ophthalmology. 2021 Apr;128(4):504-514. doi: 10.1016/j.ophtha.2020.09.002. Epub 2020 Sep 6.
9
Metabolites Interrogation in Cell Fate Decision of Cultured Human Corneal Endothelial Cells.代谢产物在人角膜内皮细胞培养中细胞命运决定中的作用研究。
Invest Ophthalmol Vis Sci. 2020 Feb 7;61(2):10. doi: 10.1167/iovs.61.2.10.
10
A physical biomarker of the quality of cultured corneal endothelial cells and of the long-term prognosis of corneal restoration in patients.一种培养的角膜内皮细胞质量的物理生物标志物,以及对患者角膜恢复的长期预后的评估。
Nat Biomed Eng. 2019 Dec;3(12):953-960. doi: 10.1038/s41551-019-0429-9. Epub 2019 Jul 22.

Fuchs 内皮角膜营养不良行培养角膜内皮细胞移植术后的角膜后弹力层小滴形态。

Guttae Morphology After Cultured Corneal Endothelial Cell Transplant in Fuchs Endothelial Corneal Dystrophy.

机构信息

Department of Ophthalmology, Kyoto Prefectural University of Medicine, Kyoto, Japan.

Center for Integrative Medicine and Physics, Institute for Advanced Study, Kyoto University, Kyoto, Japan.

出版信息

JAMA Ophthalmol. 2024 Sep 1;142(9):818-826. doi: 10.1001/jamaophthalmol.2024.2718.

DOI:10.1001/jamaophthalmol.2024.2718
PMID:39052247
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11413713/
Abstract

IMPORTANCE

Whether guttae in Fuchs endothelial corneal dystrophy (FECD) can be removed by polishing without Descemet stripping and whether postoperative maintenance of reduced guttae can be achieved through cultured corneal endothelial cell (CEC) transplant therapy are critical issues to be addressed.

OBJECTIVE

To investigate the decrease of guttae through polishing degenerated CECs and abnormal extracellular matrix (ECM) without Descemet stripping and to observe the behavior of guttae following cultured CEC transplant.

DESIGN, SETTING, AND PARTICIPANTS: This case series prospective observational study was conducted in a hospital outpatient clinic setting. Between December 2013 and January 2019, 22 eyes with corneal endothelial failure caused by FECD received cultured CEC transplant therapy at Kyoto Prefectural University Hospital. Of these, 15 eyes were consistently monitored at the same central corneal area during the preoperative phase, as well as in the early (within 1 year) and late (after 3 years) postoperative phases. The images from these phases were categorized into 3 groups: typical guttae, atypical guttae, and no guttae.

EXPOSURES

Cultured CEC transplant therapy.

MAIN OUTCOMES

Proportion of guttae in the observable area was measured, comparing the early and late postoperative phases for each group.

RESULTS

The mean age of the patients at the time of surgery was 69 years (range, 49-79 years). All 15 eyes exhibited the presence of confluent guttae preoperatively (100%). Among these, 3 of 15 eyes belonged to male patients. The early postoperative phase of guttae morphologies was classified into 3 groups: 5 eyes with typical guttae, 7 with atypical guttae, and 3 with no guttae. The decrease in the number of these guttae was achieved by surgical procedures. The median percentage of guttae in the typical guttae, atypical guttae, and no guttae groups was 41.8%, 44.4%, and 16.2%, respectively, in the early phase, and 42.2%, 38.2%, and 18.8%, respectively, in the late phase.

CONCLUSIONS AND RELEVANCE

The findings demonstrate that in some cases of FECD, guttae can be removed by scraping and polishing abnormal ECM and degenerated CECs, while preserving the Descemet membrane. Furthermore, cultured CEC transplant resulted in no increase in guttae for up to 3 years, providing insights into surgically eliminating guttae.

摘要

重要性

在不进行撕囊的情况下,通过抛光是否可以去除 Fuchs 内皮角膜营养不良(FECD)中的小泡,以及通过培养的角膜内皮细胞(CEC)移植治疗是否可以维持术后减少的小泡,这是需要解决的关键问题。

目的

研究在不撕囊的情况下通过抛光退变的 CEC 和异常细胞外基质(ECM)来减少小泡,并观察培养的 CEC 移植后的小泡行为。

设计、设置和参与者:这是一项在医院门诊环境中进行的病例系列前瞻性观察研究。在 2013 年 12 月至 2019 年 1 月期间,京都府立大学医院对 22 只因 FECD 导致的角膜内皮功能障碍的眼睛进行了培养的 CEC 移植治疗。其中,在术前阶段、早期(1 年内)和晚期(3 年后)术后阶段,对 15 只眼睛的同一中央角膜区域进行了持续监测。这些阶段的图像分为 3 组:典型小泡、非典型小泡和无小泡。

暴露

培养的 CEC 移植治疗。

主要结果

测量可观察区域中小泡的比例,比较每组的早期和晚期术后阶段。

结果

手术时患者的平均年龄为 69 岁(范围,49-79 岁)。所有 15 只眼睛术前均存在融合小泡(100%)。其中,15 只眼睛中有 3 只为男性患者。小泡形态的早期术后阶段分为 3 组:5 只眼睛有典型小泡,7 只眼睛有非典型小泡,3 只眼睛无小泡。手术程序可减少小泡数量。典型小泡、非典型小泡和无小泡组的小泡中位数百分比分别为早期 41.8%、44.4%和 16.2%,晚期 42.2%、38.2%和 18.8%。

结论和相关性

研究结果表明,在某些 FECD 病例中,通过刮除和抛光异常 ECM 和退变的 CEC 可以去除小泡,同时保留 Descemet 膜。此外,培养的 CEC 移植在 3 年内不会导致小泡增加,这为手术消除小泡提供了思路。